More articles from COPD

Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial
Sundeep Salvi, Akash Balki, Srikanth Krishnamurthy, Sagar Panchal, Saiprasad Patil, Rahul Kodgule, Hitesh Khandagale, Amol Pendse, Wen Wu, Shabbir Rangwala, Monika Tandon, Hanmant Barkate

ERJ Open Research Jul 2021, 7 (3) 00255-2021; DOI: 10.1183/23120541.00255-2021
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial
Emily P. Brigham, Julie A. Anderson, Robert D. Brook, Peter M.A. Calverley, Bartolome R. Celli, Nicholas J. Cowans, Courtney Crim, James E. Diserens, Fernando J. Martinez, Meredith C. McCormack, David E. Newby, Julie Yates, Jorgen Vestbo, Tianshi David Wu, Robert A. Wise

ERJ Open Research Jul 2021, 7 (3) 00902-2020; DOI: 10.1183/23120541.00902-2020
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease
Aparna Balasubramanian, Robert J. Henderson, Nirupama Putcha, Ashraf Fawzy, Sarath Raju, Nadia N. Hansel, Neil R. MacIntyre, Robert L. Jensen, Gregory L. Kinney, William W. Stringer, Craig P. Hersh, Russell P. Bowler, Richard Casaburi, MeiLan K. Han, Janos Porszasz, Barry J. Make, Meredith C. McCormack, Robert A. Wise

ERJ Open Research Jul 2021, 7 (3) 00068-2021; DOI: 10.1183/23120541.00068-2021
MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations
Martin I. MacDonald, Christian R. Osadnik, Lauren Bulfin, Elizabeth Leahy, Paul Leong, Eskandarain Shafuddin, Kais Hamza, Paul T. King, Philip G. Bardin

ERJ Open Research Jul 2021, 7 (3) 00198-2021; DOI: 10.1183/23120541.00198-2021
The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
Benedikt Ditz, Aartik Sarma, Huib A.M. Kerstjens, Jeroen J.W. Liesker, Erik Bathoorn, Judith M. Vonk, Victor Bernal, Peter Horvatovich, Victor Guryev, Saharai Caldera, Chaz Langelier, Alen Faiz, Stephanie A. Christenson, Maarten van den Berge

ERJ Open Research Jul 2021, 7 (3) 00097-2021; DOI: 10.1183/23120541.00097-2021
Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study
Leila Karimi, Lies Lahousse, Phebe De Nocker, Bruno H. Stricker, Guy G. Brusselle, Katia M.C. Verhamme

ERJ Open Research Apr 2021, 7 (2) 00624-2020; DOI: 10.1183/23120541.00624-2020
Swallowing dysfunction in patients hospitalised due to a COPD exacerbation
Margareta Gonzalez Lindh, Christer Janson, Monica Blom Johansson, Mimmi Jonsson, Emma Mälberg, Elina Allansson, Cecilia Holm, Margareta Jennische, Hirsch Koyi

ERJ Open Research Apr 2021, 7 (2) 00173-2021; DOI: 10.1183/23120541.00173-2021
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton

ERJ Open Research Apr 2021, 7 (2) 00950-2020; DOI: 10.1183/23120541.00950-2020
Increased myofibroblasts in the small airways, and relationship to remodelling and functional changes in smokers and COPD patients: potential role of epithelial–mesenchymal transition
Mathew Suji Eapen, Wenying Lu, Tillie L. Hackett, Gurpreet Kaur Singhera, Malik Q. Mahmood, Ashutosh Hardikar, Chris Ward, Eugene Haydn Walters, Sukhwinder Singh Sohal

ERJ Open Research Apr 2021, 7 (2) 00876-2020; DOI: 10.1183/23120541.00876-2020
Lung volume reduction in emphysema: a pragmatic prospective cohort study
Christophe Dooms, Astrid Blondeel, Laurens J. Ceulemans, Johan Coolen, Stephanie Everaerts, Heleen Demeyer, Thierry Troosters, Geert Verleden, Dirk Van Raemdonck, Wim Janssens

ERJ Open Research Apr 2021, 7 (2) 00877-2020; DOI: 10.1183/23120541.00877-2020

Main menu

User menu

Search

More articles from COPD

Pages

Contact us